Marc K. Hellerstein, MD, PhD
Elected 1994
Metabolic control of disease-modifying pathways in vivo, in living organisms. Measurement of fluxes in complex metabolic networks. Translational medicine and drug development using functional metrics (biomarkers) of disease activity.